New trends in the development of oral antidiabetic drugs

被引:43
作者
Kecskemeti, V
Bagi, Z
Pacher, P
Posa, I
Kocsis, E
Koltai, MZ
机构
[1] Semmelweis Univ Budapest, Dept Pharmacol & Pharmacotherapy, H-1445 Budapest, Hungary
[2] Gottsegen Gy Hungarian Inst Cardiol, Budapest, Hungary
关键词
D O I
10.2174/0929867023371427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A large number of oral antidiabetic agents are available today. This article provides a short review of the pharmacology and some clinical aspects of various oral ? antidiabetic drugs. It focuses mainly on the newest developing drugs (therapy of the near future) and on the most commonly used older groups for the common approach of everyday practice (sulphonylureas). The primary goal of this review is to compare the electrophysiological effects of glibenclamide in isolated normal and streptozotocin induced diabetic rats and alloxan induced rabbits ventricular preparations, while on the other hand to differentiate the hypoglycaemic sulphonylureas (0.1-1000 mumol/kg) according to their cardiovascular activity in healthy and diabetic animals. In vitro (1-100 mumol/l) as well as chronically treated (5 mg/kg for 10 weeks) glibenclamide prolonged the action potential duration in normal but failed to affect it in diabetic ventricular preparations. Our results suggest that the sensitivity to glibenclamide of K-ATP channels in diabetic ventricular fibers is drastically decreased. The effects of different sulphonylureas (tolbutamide, glibenclamide, gliclazide, glimepiride) on ventricular ectopic beats as well as the duration of ventricular fibrillation induced by 10 min ischemia/50 min reperfusion in healthy and diabetic rats were compared. Tolbutamide and gliclazide dose-dependently enhanced both parameters both in healthy and diabetic groups. Glibenclamide in healthy rats increased, while in diabetic rats it decreased the arrhythmogenicity. Glimepiride depressed the arrhythmogenicity in both healthy and diabetic animals. Glimepiride proved to dose-dependently enhance the myocardial tissue flow in dog in contrast to glibenclamide. These results confirm that glimepiride has less cardiovascular actions than other sulphonylureas. From the newest oral antidiabetics this review tries to emphasize the most important basic pharmacological properties, mechanism of action, therapeutic use.
引用
收藏
页码:53 / 71
页数:19
相关论文
共 196 条
[1]
AIRAKSINEN KEJ, 1985, ANN CLIN RES, V17, P135
[2]
INCREASED SUSCEPTIBILITY TO HYPOXIA OF PROLONGED ACTION-POTENTIAL DURATION IN VENTRICULAR PAPILLARY-MUSCLES FROM DIABETIC RATS [J].
AOMINE, M ;
NOBE, S ;
ARITA, M .
DIABETES, 1990, 39 (12) :1485-1489
[3]
CHARACTERIZATION OF 2 DISTINCT DEPOLARIZATION-ACTIVATED K+ CURRENTS IN ISOLATED ADULT-RAT VENTRICULAR MYOCYTES [J].
APKON, M ;
NERBONNE, JM .
JOURNAL OF GENERAL PHYSIOLOGY, 1991, 97 (05) :973-1011
[4]
GLUCOSE INDUCES CLOSURE OF SINGLE POTASSIUM CHANNELS IN ISOLATED RAT PANCREATIC BETA-CELLS [J].
ASHCROFT, FM ;
HARRISON, DE ;
ASHCROFT, SJH .
NATURE, 1984, 312 (5993) :446-448
[5]
EFFECT OF THE SULFONYLUREA GLYBURIDE ON GLYCOGEN-SYNTHESIS IN ALLOXAN-INDUCED DIABETIC RAT HEPATOCYTES [J].
ATALAY, T ;
ALTAN, N ;
ONGUN, CO ;
ALAGOL, H .
GENERAL PHARMACOLOGY, 1994, 25 (07) :1435-1437
[6]
DIRECT STIMULATION OF MYOCARDIAL GLUCOSE-TRANSPORT AND GLUCOSE TRANSPORTER-1 (GLUT1) AND GLUT4 PROTEIN EXPRESSION BY THE SULFONYLUREA GLIMEPIRIDE [J].
BAHR, M ;
VONHOLTEY, M ;
MULLER, G ;
ECKEL, J .
ENDOCRINOLOGY, 1995, 136 (06) :2547-2553
[7]
Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes [J].
Bahr, M ;
Spelleken, M ;
Bock, M ;
vonHoltey, M ;
Kiehn, R ;
Eckel, J .
DIABETOLOGIA, 1996, 39 (07) :766-774
[8]
BAILEY C. J, 2000, PRACT DIAB INT, V17, P135
[9]
BIGUANIDES AND NIDDM [J].
BAILEY, CJ .
DIABETES CARE, 1992, 15 (06) :755-772
[10]
Potential new treatments for type 2 diabetes [J].
Bailey, CJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) :259-265